pantoprazole has been researched along with diclofenac in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Avdeef, A; Tam, KY | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bliesath, H; Huber, R; Koch, HJ; Mascher, H; Steinijans, VW; Wurst, W | 2 |
| Abramo, A; Antonioli, L; Baldi, S; Blandizzi, C; Carazzina, G; Colucci, R; Del Tacca, M; Fornai, M; Lubrano, V; Natale, G; Tuccori, M | 1 |
| Guhathakarta, S; Karthikeyan, K; Korrapati, PS; Rajaram, R | 1 |
| Bhatt, NM; Chavada, VD; Sanyal, M; Shrivastav, PS | 1 |
1 review(s) available for pantoprazole and diclofenac
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for pantoprazole and diclofenac
| Article | Year |
|---|---|
Lack of pharmacokinetic interaction between pantoprazole and diclofenac.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Anticonvulsants; Area Under Curve; Benzimidazoles; Cross-Over Studies; Diclofenac; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides | 1996 |
Lack of pharmacokinetic interaction between pantoprazole and diclofenac.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Benzimidazoles; Biological Availability; Blood Pressure; Diclofenac; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Omeprazole; Pantoprazole; Random Allocation; Sulfoxides | 1996 |
11 other study(ies) available for pantoprazole and diclofenac
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Diclofenac; Dose-Response Relationship, Drug; Gastric Acid; Gastric Mucosa; Glutathione; Indomethacin; Ligation; Lipoproteins, LDL; Male; Malondialdehyde; Omeprazole; Oxidation-Reduction; Pantoprazole; Peroxidase; Piroxicam; Proton Pump Inhibitors; Pylorus; Rats; Rats, Wistar; Sulfoxides | 2005 |
Electrospun zein/eudragit nanofibers based dual drug delivery system for the simultaneous delivery of aceclofenac and pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Carriers; Drug Combinations; Drug Compounding; Gastric Mucosa; Nanofibers; Pantoprazole; Polymethacrylic Acids; Proton Pump Inhibitors; Rats; Rats, Wistar; Zein | 2012 |
Manipulating ratio spectra for the spectrophotometric analysis of diclofenac sodium and pantoprazole sodium in laboratory mixtures and tablet formulation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Analysis of Variance; Calibration; Chemistry, Pharmaceutical; Diclofenac; Pantoprazole; Reproducibility of Results; Spectrophotometry; Tablets | 2014 |